⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 17, 2011Antimicrobial Agents and ChemotherapyOpen Access

Low Prevalence of bla OXA-143 in Private Hospitals in Brazil

Jessica Sanchez de Freitas Werneck Renata Cristina Picão Raquel Girardello Rodrigo Cayô Vitor Marguti Líbera Maria Dalla-Costa Ana Cristina Gales Charline Santos Antonio Patrícia Neves Micheli Medeiros Elsa Masae Mamizuka Maria Rita Elmor de Araújo Nilton Lincopán

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Universidade Federal de São Paulo UNIFESP, Div Infect Dis, Lab ALERTA, São Paulo, Brazil

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Werneck et al. (2011) studied this question.

synapsesocial.com/papers/6ab1d26522725abcd3a9aa57 https://doi.org/10.1128/aac.00295-11

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1High Prevalence of Carbapenem-Resistant Acinetobacter baumannii Carrying the bla OXA-143 Gene in Brazilian HospitalsOriginal Research · 2010 · 51 citations
2Outbreak of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Producing the OXA-23 Enzyme in Curitiba, BrazilOriginal Research · 2003 · 196 citations
3OXA-143, a Novel Carbapenem-Hydrolyzing Class D β-Lactamase in <i>Acinetobacter baumannii</i>Original Research · 2009 · 228 citations
4Rapid Detection and Identification of Metallo-β-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve AnalysisOriginal Research · 2006 · 287 citations
5OXA-72-producing Acinetobacter baumannii in Brazil: a case reportCase Report · 2010 · 55 citations

More related papers

Dissemination in distinct Brazilian regions of an epidemiccarbapenem-resistant Pseudomonas aeruginosa producing SPM metallo- -lactamase2003
Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme2002

More from Antimicrobial Agents and Chemotherapy

Activity of oral β-lactams, tebipenem and ceftibuten, combined with novel oral β-lactamase inhibitors against broad-spectrum β-lactamase-producing Escherichia coliWed,
Rifampicin-resistant Staphylococcus epidermidis implant-associated infections: the therapeutic potential of ceftaroline and daptomycin combinationsWed,
Expanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones disseminationWed,